News & Analysis on Clinical Trial Services & Contract Research And Development
By Natalie Morrison
- Last updated on
Interpace BioPharma - a subsidiary of PDI - was formed to manage full product commercialization projects, and recently signed a two-and-a-half-year agreement for the sales and marketing of a treatment for knee pain.
Parsons takes the reins after a stint as president and chief commercial officer of the US division of biopharmaceutical company TopoTarget A/S.